Evidence map›Paper›PMID 22919583›Full record

ArticleFrontiers in cellular and infection microbiology2011

Major host factors involved in epithelial cell invasion of Campylobacter jejuni: role of fibronectin, integrin beta1, FAK, Tiam-1, and DOCK180 in activating Rho GTPase Rac1.

Manja Boehm, Malgorzata Krause-Gruszczynska, Manfred Rohde, Nicole Tegtmeyer, Seiichiro Takahashi, Omar A Oyarzabal, Steffen Backert

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
11.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic and protective approaches to combatFrontiers in pharmacology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Molecular Targets inBiomolecules · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Antimicrobial agents and chemotherapy · 2022
    Article
  13. Recruitment of LC3 byFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Cancers · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Effect of Sugars onPathogens (Basel, Switzerland) · 2020
    Article
  20. Molecular Dissection of theMicroorganisms · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Manja BoehmSchool for Biomedical and Biomolecular Science, Belfield Campus, University College Dublin, Dublin, Ireland; Department of Microbiology, Otton von Guericke University, Magdeburg, Germany.
Malgorzata Krause-Gruszczynska
Manfred Rohde
Nicole Tegtmeyer
Seiichiro Takahashi
Omar A Oyarzabal
Steffen Backert
Otto-von-Guericke University Magdeburg · DEAlabama State University · USHelmholtz Centre for Infection Research · DEMax Planck Institute of Biochemistry · DEUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Host cell entry by the food-borne pathogen Campylobacter jejuni has been reported as one of the primary reasons of tissue damage in infected humans, however, molecular invasion mechanisms and cellular factors involved in this process are widely unclear. Here we used knockout cell lines derived from fibronectin(-/-), integrin beta1(-/-), and focal adhesion kinase (FAK)(-/-) deficient mice and corresponding wild-type (WT) controls, to study C. jejuni-induced signaling cascades involved in the bacterial invasion process. Using high resolution scanning electron microscopy, GTPase pull-downs, G-LISA, and gentamicin protection assays we found that each of these host cell factors is indeed required for activation of the small Rho GTPase member Rac1 and maximal host cell invasion of this pathogen. Interestingly, membrane ruffling, tight engulfment of bacteria and invasion were only seen during infection of WT control cells, but not in fibronectin(-/-), integrin beta1(-/-), and FAK(-/-) knockout cell lines. We also demonstrate that C. jejuni activates FAK autophosphorylation activity at Y-397 and phosphorylation of Y-925, which is required for stimulating two downstream guanine exchange factors, DOCK180 and Tiam-1, which are upstream of Rac1. Small interfering (si) RNA studies further show that DOCK180 and Tiam-1 act cooperatively to trigger Rac1 activation and C. jejuni invasion. Moreover, mutagenesis data indicate that the bacterial fibronectin-binding protein CadF and the intact flagellum are involved in Rho GTPase activation and host cell invasion. Collectively, our results suggest that C. jejuni infection of host epithelial target cells hijacks a major fibronectin → integrin beta1 → FAK → DOCK180/Tiam-1 signaling cascade, which has a crucial role for Rac1 GTPase activity and bacterial entry into host target cells.

Indexed as

AnimalsBacterial Outer Membrane ProteinsBase SequenceCampylobacter InfectionsCampylobacter jejuniCarrier ProteinsCell LineEnzyme ActivationEpithelial CellsFibronectinsFocal Adhesion Kinase 1Genes, BacterialGuanine Nucleotide Exchange FactorsHost-Pathogen InteractionsHumansIntegrin beta1Bacterial Outer Membrane ProteinsCadF protein, Campylobacter jejuniCarrier ProteinsDock180 protein, mouseDOCK1 protein, humanFibronectinsFocal Adhesion Kinase 1Guanine Nucleotide Exchange FactorsIntegrin beta1NeuropeptidesPtk2 protein, mouserac1 GTP-Binding ProteinRAC1 protein, humanRac1 protein, mouserac GTP-Binding ProteinsRNA, Small InterferingTiam1 protein, mouseT-Lymphoma Invasion and Metastasis-inducing Protein 1cellular invasionmolecular pathogenesisRho family GTPasessignalingvirulence

Identifiers

PMID22919583
PMCPMC3417370
OpenAlexW2162100190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.